.RESEARCH STUDY HIGHLIGHT.06 August 2024.
A big randomized controlled trial with cisgender women highlights the obstacles of fidelity to a day-to-day dental preexposure prevention regiment as well as illustrates that twice-yearly shot of lenacapavir can easily preserve effective HIV deterrence degrees over 6 months.